Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
97.34 USD | -0.16% | -1.74% | -3.60% |
05-02 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
05-02 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Sales 2024 * | 48.85B 3,892B | Sales 2025 * | 50.67B 4,037B | Capitalization | 199B 15,830B |
---|---|---|---|---|---|
Net income 2024 * | 10.2B 813B | Net income 2025 * | 11.93B 950B | EV / Sales 2024 * | 4.33 x |
Net Debt 2024 * | 12.79B 1,019B | Net Debt 2025 * | 11.32B 902B | EV / Sales 2025 * | 4.15 x |
P/E ratio 2024 * |
19.3
x | P/E ratio 2025 * |
16.6
x | Employees | 76,057 |
Yield 2024 * |
3.7% | Yield 2025 * |
3.84% | Free-Float | 85.22% |
Latest transcript on Novartis AG
1 day | -0.16% | ||
1 week | -1.74% | ||
Current month | +0.22% | ||
1 month | +3.10% | ||
3 months | -6.15% | ||
6 months | +3.47% | ||
Current year | -3.60% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 31/12/04 | |
Director of Finance/CFO | 59 | 31/12/02 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/05/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 31/12/12 |
Simon Moroney
BRD | Director/Board Member | 65 | 27/02/20 |
Chairman | 68 | 31/12/12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
8.01% | 13 M€ | -.--% | ||
1.52% | 9 M€ | -4.31% | - |
Date | Price | Change | Volume |
---|---|---|---|
02/05/24 | 97.34 | -0.16% | 1,426,052 |
01/05/24 | 97.5 | +0.38% | 1,284,177 |
30/04/24 | 97.13 | +0.04% | 1,630,756 |
29/04/24 | 97.09 | -0.36% | 2,168,689 |
26/04/24 | 97.44 | -1.64% | 1,562,845 |
Delayed Quote Nyse, May 02, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+3.77% | 286B | |
+14.68% | 236B | |
-12.43% | 194B | |
-3.79% | 154B | |
-3.34% | 149B |
- Stock Market
- Equities
- NOVN Stock
- NVS Stock